Overwhelming majority passes new EMA powers

The European Parliament has adopted regulation that strengthens the EMA's ability to monitor drug and medical equipment shortages in Europe. New EMA groups will be impartial, they say, effectively shutting the door on representatives from the medical industry at large.

Photo: Piroschka Van De Wouw/Reuters/Ritzau Scanpix

STRASBOURG – The European Medicines Agency (EMA) is getting a string of new powers to manage drug and medical equipment shortages in Europe, as the European Commission officially adopts an agreement that strengthens the role of the agency on Wednesday.

Going forward, the EMA will have more instruments when it comes monitoring drugs and medical equipment that are deemed critical in times of crises.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs